Skip to main content
Top

Open Access 04-09-2024 | Doxycycline | Case Series

Mycoplasma hominis as Cause of Extragenital Infection in Patients with Hypogammaglobulinemia: Report of 2 Cases and Literature Review

Authors: Chiara Russo, Malgorzata Mikulska, Emanuele Delfino, Federica Toscanini, Laura Mezzogori, Riccardo Schiavoni, Claudia Bartalucci, Emanuele Angelucci, Giulia Bartalucci, Massimiliano Gambella, Anna Maria Raiola, Paola Morici, Francesca Crea, Silvia Chiola, Silvia Daniela Morbelli, Anna Marchese, Matteo Bassetti

Published in: Infectious Diseases and Therapy

Login to get access

Abstract

Mycoplasma hominis can be a part of human urogenital tract microbiome, and it is a frequent cause of urogenital infections. In rare cases, it can also cause extragenital infections, especially in immunocompromised patients. In this case series, we report two cases and provide a literature review of extragenital infections caused by M. hominis in patients with hypogammaglobulinemia. Patient 1 was a 61-year-old woman with diffuse large B-cell lymphoma who, after rituximab-containing chemotherapy and CAR-T therapy, developed M. hominis spondylodiscitis. Patient 2 was a 50-year-old woman with congenital hypogammaglobulinemia who developed disseminated M. hominis infection involving pleura, muscles, and right ankle. Antibiotic therapy with levofloxacin and doxycycline for 10 weeks in patient 1 and with levofloxacin alone for 6 weeks in patient 2 led to infection resolution. The literature review identified 14 additional cases reporting M. hominis extragenital infection in patients with hypogammaglobulinemia. M. hominis should also be suspected as an etiological agent of extragenital infection in patients with B-cell immunodeficiency with a clinical picture of persistent, standard-culture negative infection, particularly with arthritis or abscess formation. Even if M. hominis can grow on standard bacterial medium, in suspected cases molecular methods should be promptly used for correct diagnostic work-up and successful therapy.
Literature
1.
go back to reference Ahmed J, et al. Mycoplasma hominis: an under recognized pathogen. Indian J Med Microbiol. 2021;39(1):88–97.PubMedCrossRef Ahmed J, et al. Mycoplasma hominis: an under recognized pathogen. Indian J Med Microbiol. 2021;39(1):88–97.PubMedCrossRef
2.
go back to reference Pettersson B, et al. Updated phylogenetic description of the Mycoplasma hominis cluster (Weisburg et al. 1989) based on 16S rDNA sequences. Int J Syst Evol Microbiol. 2000;50 Pt 1:291–301.PubMedCrossRef Pettersson B, et al. Updated phylogenetic description of the Mycoplasma hominis cluster (Weisburg et al. 1989) based on 16S rDNA sequences. Int J Syst Evol Microbiol. 2000;50 Pt 1:291–301.PubMedCrossRef
3.
go back to reference Taylor-Robinson D. Mollicutes in vaginal microbiology: Mycoplasma hominis, Ureaplasma urealyticum, Ureaplasma parvum and Mycoplasma genitalium. Res Microbiol. 2017;168(9–10):875–81.PubMedCrossRef Taylor-Robinson D. Mollicutes in vaginal microbiology: Mycoplasma hominis, Ureaplasma urealyticum, Ureaplasma parvum and Mycoplasma genitalium. Res Microbiol. 2017;168(9–10):875–81.PubMedCrossRef
4.
go back to reference Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, vol. 2. 9th ed. Amsterdam: Elsevier; 2019. Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, vol. 2. 9th ed. Amsterdam: Elsevier; 2019.
5.
go back to reference Horner P, et al. Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women?—a position statement from the European STI Guidelines Editorial Board. J Eur Acad Dermatol Venereol. 2018;32(11):1845–51.PubMedCrossRef Horner P, et al. Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women?—a position statement from the European STI Guidelines Editorial Board. J Eur Acad Dermatol Venereol. 2018;32(11):1845–51.PubMedCrossRef
6.
go back to reference Leli C, et al. Prevalence of cervical colonization by Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium in childbearing age women by a commercially available multiplex real-time PCR: an Italian observational multicentre study. J Microbiol Immunol Infect. 2018;51(2):220–5.PubMedCrossRef Leli C, et al. Prevalence of cervical colonization by Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium in childbearing age women by a commercially available multiplex real-time PCR: an Italian observational multicentre study. J Microbiol Immunol Infect. 2018;51(2):220–5.PubMedCrossRef
7.
go back to reference Plummer EL, et al. Are Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum associated with specific genital symptoms and clinical signs in nonpregnant women? Clin Infect Dis. 2021;73(4):659–68.PubMedCrossRef Plummer EL, et al. Are Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum associated with specific genital symptoms and clinical signs in nonpregnant women? Clin Infect Dis. 2021;73(4):659–68.PubMedCrossRef
8.
go back to reference Madoff S, Hooper DC. Nongenitourinary infections caused by Mycoplasma hominis in adults. Rev Infect Dis. 1988;10(3):602–13.PubMedCrossRef Madoff S, Hooper DC. Nongenitourinary infections caused by Mycoplasma hominis in adults. Rev Infect Dis. 1988;10(3):602–13.PubMedCrossRef
9.
go back to reference McMahon DK, et al. Extragenital Mycoplasma hominis infections in adults. Am J Med. 1990;89(3):275–81.PubMedCrossRef McMahon DK, et al. Extragenital Mycoplasma hominis infections in adults. Am J Med. 1990;89(3):275–81.PubMedCrossRef
10.
go back to reference Meyer RD, Clough W. Extragenital Mycoplasma hominis infections in adults: emphasis on immunosuppression. Clin Infect Dis. 1993;17(Suppl 1):S243–9.PubMedCrossRef Meyer RD, Clough W. Extragenital Mycoplasma hominis infections in adults: emphasis on immunosuppression. Clin Infect Dis. 1993;17(Suppl 1):S243–9.PubMedCrossRef
11.
go back to reference Roifman CM, et al. Increased susceptibility to Mycoplasma infection in patients with hypogammaglobulinemia. Am J Med. 1986;80(4):590–4.PubMedCrossRef Roifman CM, et al. Increased susceptibility to Mycoplasma infection in patients with hypogammaglobulinemia. Am J Med. 1986;80(4):590–4.PubMedCrossRef
12.
go back to reference Tawfik P, Arndt P. Lethal hyperammonemia in a CAR-T cell recipient due to ureaplasma pneumonia: a case report of a unique severe complication. BMJ Case Rep. 2021;14(7): e242513.PubMedPubMedCentralCrossRef Tawfik P, Arndt P. Lethal hyperammonemia in a CAR-T cell recipient due to ureaplasma pneumonia: a case report of a unique severe complication. BMJ Case Rep. 2021;14(7): e242513.PubMedPubMedCentralCrossRef
13.
go back to reference Machado P, et al. Arthritis and X-linked agammaglobulinemia. Acta Reumatol Port. 2008;33(4):464–7.PubMed Machado P, et al. Arthritis and X-linked agammaglobulinemia. Acta Reumatol Port. 2008;33(4):464–7.PubMed
14.
go back to reference Hansel TT, Haeney MR, Thompson RA. Primary hypogammaglobulinaemia and arthritis. Br Med J (Clin Res Ed). 1987;295(6591):174–5.PubMedCrossRef Hansel TT, Haeney MR, Thompson RA. Primary hypogammaglobulinaemia and arthritis. Br Med J (Clin Res Ed). 1987;295(6591):174–5.PubMedCrossRef
15.
go back to reference Barmettler S, et al. Association of immunoglobulin levels, infectious risk, and mortality with rituximab and hypogammaglobulinemia. JAMA Netw Open. 2018;1(7): e184169.PubMedPubMedCentralCrossRef Barmettler S, et al. Association of immunoglobulin levels, infectious risk, and mortality with rituximab and hypogammaglobulinemia. JAMA Netw Open. 2018;1(7): e184169.PubMedPubMedCentralCrossRef
16.
go back to reference Clough W, et al. Septic arthritis and bacteremia due to Mycoplasma resistant to antimicrobial therapy in a patient with systemic lupus erythematosus. Clin Infect Dis. 1992;15(3):402–7.PubMedCrossRef Clough W, et al. Septic arthritis and bacteremia due to Mycoplasma resistant to antimicrobial therapy in a patient with systemic lupus erythematosus. Clin Infect Dis. 1992;15(3):402–7.PubMedCrossRef
17.
go back to reference Furr PM, Taylor-Robinson D, Webster AD. Mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and their role in arthritis: microbiological observations over twenty years. Ann Rheum Dis. 1994;53(3):183–7.PubMedPubMedCentralCrossRef Furr PM, Taylor-Robinson D, Webster AD. Mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and their role in arthritis: microbiological observations over twenty years. Ann Rheum Dis. 1994;53(3):183–7.PubMedPubMedCentralCrossRef
18.
go back to reference Webster AD, et al. Critical dependence on antibody for defence against mycoplasmas. Clin Exp Immunol. 1988;71(3):383–7.PubMedPubMedCentral Webster AD, et al. Critical dependence on antibody for defence against mycoplasmas. Clin Exp Immunol. 1988;71(3):383–7.PubMedPubMedCentral
19.
go back to reference Taylor-Robinson D, Furr PM, Webster AD. Ureaplasma urealyticum in the immunocompromised host. Pediatr Infect Dis. 1986;5(6 Suppl):S236–8.PubMedCrossRef Taylor-Robinson D, Furr PM, Webster AD. Ureaplasma urealyticum in the immunocompromised host. Pediatr Infect Dis. 1986;5(6 Suppl):S236–8.PubMedCrossRef
21.
go back to reference Su F, et al. Identification of sacrococcygeal and pelvic abscesses infected with invasive Mycoplasma hominis by MALDI-TOF MS. J Clin Lab Anal. 2022;36(4): e24329.PubMedPubMedCentralCrossRef Su F, et al. Identification of sacrococcygeal and pelvic abscesses infected with invasive Mycoplasma hominis by MALDI-TOF MS. J Clin Lab Anal. 2022;36(4): e24329.PubMedPubMedCentralCrossRef
22.
go back to reference Waites KB, et al. Molecular methods for the detection of Mycoplasma and ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology. J Mol Diagn. 2012;14(5):437–50.PubMedPubMedCentralCrossRef Waites KB, et al. Molecular methods for the detection of Mycoplasma and ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology. J Mol Diagn. 2012;14(5):437–50.PubMedPubMedCentralCrossRef
23.
go back to reference Frolund M, et al. Comparison between culture and a multiplex quantitative real-time polymerase chain reaction assay detecting Ureaplasma urealyticum and U. parvum. PLoS One. 2014;9(7): e102743.PubMedPubMedCentralCrossRef Frolund M, et al. Comparison between culture and a multiplex quantitative real-time polymerase chain reaction assay detecting Ureaplasma urealyticum and U. parvum. PLoS One. 2014;9(7): e102743.PubMedPubMedCentralCrossRef
24.
25.
go back to reference Hazra A, Collison MW, Davis AM. CDC sexually transmitted infections treatment guidelines, 2021. JAMA. 2022;327(9):870–1.PubMedCrossRef Hazra A, Collison MW, Davis AM. CDC sexually transmitted infections treatment guidelines, 2021. JAMA. 2022;327(9):870–1.PubMedCrossRef
27.
go back to reference WHO. Guidelines for the management of symptomatic sexually transmitted infections. Geneva: WHO; 2021. WHO. Guidelines for the management of symptomatic sexually transmitted infections. Geneva: WHO; 2021.
28.
go back to reference Krausse R, Schubert S. In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years. Clin Microbiol Infect. 2010;16(11):1649–55.PubMedCrossRef Krausse R, Schubert S. In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years. Clin Microbiol Infect. 2010;16(11):1649–55.PubMedCrossRef
29.
go back to reference Samra Z, Rosenberg S, Dan M. Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin. J Chemother. 2011;23(2):77–9.PubMedCrossRef Samra Z, Rosenberg S, Dan M. Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin. J Chemother. 2011;23(2):77–9.PubMedCrossRef
30.
go back to reference Niccoli Asabella A, et al. Role of (18)F-FDG PET/CT in the evaluation of response to antibiotic therapy in patients affected by infectious spondylodiscitis. Hell J Nucl Med. 2015;18(Suppl 1):17–22.PubMed Niccoli Asabella A, et al. Role of (18)F-FDG PET/CT in the evaluation of response to antibiotic therapy in patients affected by infectious spondylodiscitis. Hell J Nucl Med. 2015;18(Suppl 1):17–22.PubMed
32.
go back to reference Divithotewala C, et al. Mycoplasma hominis and Ureaplasma urealyticum infections in the immediate post-lung transplant period: a case series and literature review. Transpl Infect Dis. 2023;25(3): e14058.PubMedCrossRef Divithotewala C, et al. Mycoplasma hominis and Ureaplasma urealyticum infections in the immediate post-lung transplant period: a case series and literature review. Transpl Infect Dis. 2023;25(3): e14058.PubMedCrossRef
33.
go back to reference Farfour E, Vasse M, Vallee A. Mollicutes-related infections in thoracic surgery including lung and heart transplantation: a systematic review. J Heart Lung Transplant. 2024;43(1):169–80.PubMedCrossRef Farfour E, Vasse M, Vallee A. Mollicutes-related infections in thoracic surgery including lung and heart transplantation: a systematic review. J Heart Lung Transplant. 2024;43(1):169–80.PubMedCrossRef
34.
go back to reference Tam PCK, et al. Risk factors, management, and clinical outcomes of invasive Mycoplasma and Ureaplasma infections after lung transplantation. Am J Transplant. 2024;24(4):641–52.PubMedCrossRef Tam PCK, et al. Risk factors, management, and clinical outcomes of invasive Mycoplasma and Ureaplasma infections after lung transplantation. Am J Transplant. 2024;24(4):641–52.PubMedCrossRef
35.
go back to reference Steuer A, et al. Common variable immunodeficiency presenting as a Mycoplasma hominis septic arthritis. J Infect. 1996;33(3):235–7.PubMedCrossRef Steuer A, et al. Common variable immunodeficiency presenting as a Mycoplasma hominis septic arthritis. J Infect. 1996;33(3):235–7.PubMedCrossRef
36.
go back to reference Franz A, et al. Mycoplasmal arthritis in patients with primary immunoglobulin deficiency: clinical features and outcome in 18 patients. Br J Rheumatol. 1997;36(6):661–8.PubMedCrossRef Franz A, et al. Mycoplasmal arthritis in patients with primary immunoglobulin deficiency: clinical features and outcome in 18 patients. Br J Rheumatol. 1997;36(6):661–8.PubMedCrossRef
37.
go back to reference Heilmann C, et al. Treatment of resistant mycoplasma infection in immunocompromised patients with a new pleuromutilin antibiotic. J Infect. 2001;43(4):234–8.PubMedCrossRef Heilmann C, et al. Treatment of resistant mycoplasma infection in immunocompromised patients with a new pleuromutilin antibiotic. J Infect. 2001;43(4):234–8.PubMedCrossRef
38.
go back to reference Sendi P, Zimmerli W, Michot M. Spondylitis and arthritis due to Mycoplasma hominis: the case for awareness in undefined pleuropneumonia. Clin Infect Dis. 2004;39(8):1250–1.PubMedCrossRef Sendi P, Zimmerli W, Michot M. Spondylitis and arthritis due to Mycoplasma hominis: the case for awareness in undefined pleuropneumonia. Clin Infect Dis. 2004;39(8):1250–1.PubMedCrossRef
39.
go back to reference MacKenzie CR, et al. Fatal outcome of a disseminated dual infection with drug-resistant Mycoplasma hominis and Ureaplasma parvum originating from a septic arthritis in an immunocompromised patient. Int J Infect Dis. 2010;14(Suppl 3):e307–9.PubMedCrossRef MacKenzie CR, et al. Fatal outcome of a disseminated dual infection with drug-resistant Mycoplasma hominis and Ureaplasma parvum originating from a septic arthritis in an immunocompromised patient. Int J Infect Dis. 2010;14(Suppl 3):e307–9.PubMedCrossRef
40.
go back to reference Wynes J, et al. Subtalar joint septic arthritis in a patient with hypogammaglobulinemia. J Foot Ankle Surg. 2013;52(2):242–8.PubMedCrossRef Wynes J, et al. Subtalar joint septic arthritis in a patient with hypogammaglobulinemia. J Foot Ankle Surg. 2013;52(2):242–8.PubMedCrossRef
41.
go back to reference Sato H, et al. Hypogammaglobulinemic patient with polyarthritis mimicking rheumatoid arthritis finally diagnosed as septic arthritis caused by Mycoplasma hominis. Intern Med. 2012;51(4):425–9.PubMedCrossRef Sato H, et al. Hypogammaglobulinemic patient with polyarthritis mimicking rheumatoid arthritis finally diagnosed as septic arthritis caused by Mycoplasma hominis. Intern Med. 2012;51(4):425–9.PubMedCrossRef
42.
go back to reference Nulens E, et al. A disseminated Mycoplasma hominis infection in a patient with an underlying defect in humoral immunity. Infection. 2016;44(3):379–81.PubMedCrossRef Nulens E, et al. A disseminated Mycoplasma hominis infection in a patient with an underlying defect in humoral immunity. Infection. 2016;44(3):379–81.PubMedCrossRef
43.
go back to reference Ali GA, et al. An enemy in shadows-Mycoplasma hominis septic arthritis and iliopsoas abscess: case report and review of the literature. IDCases. 2021;26: e01260.PubMedPubMedCentralCrossRef Ali GA, et al. An enemy in shadows-Mycoplasma hominis septic arthritis and iliopsoas abscess: case report and review of the literature. IDCases. 2021;26: e01260.PubMedPubMedCentralCrossRef
44.
Metadata
Title
Mycoplasma hominis as Cause of Extragenital Infection in Patients with Hypogammaglobulinemia: Report of 2 Cases and Literature Review
Authors
Chiara Russo
Malgorzata Mikulska
Emanuele Delfino
Federica Toscanini
Laura Mezzogori
Riccardo Schiavoni
Claudia Bartalucci
Emanuele Angelucci
Giulia Bartalucci
Massimiliano Gambella
Anna Maria Raiola
Paola Morici
Francesca Crea
Silvia Chiola
Silvia Daniela Morbelli
Anna Marchese
Matteo Bassetti
Publication date
04-09-2024
Publisher
Springer Healthcare
Published in
Infectious Diseases and Therapy
Print ISSN: 2193-8229
Electronic ISSN: 2193-6382
DOI
https://doi.org/10.1007/s40121-024-01035-9

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more